ARCHIVES

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Budget Resolution Includes Extra Money For NCI

July 2, 1982

CPT-11, Gemcitabine Increase Survival Of Pancreatic Cancer

March 29, 2002

Treatment IND or GM-CSF Is Approved

October 5, 1990

In Brief: Holland Recovering From Coronary Bypass; Henry Kaplan Receives Annual Prentis Award

July 25, 1980

NCI to Implement More Transparent Formula For Calculating Cancer Center Support Grants

June 11, 2014

Fountain Displays Some Statesmanship

July 8, 1977